Cooper Companies, Inc. (The) (COO) Shares Sold by Los Angeles Capital Management & Equity Research Inc.

Los Angeles Capital Management & Equity Research Inc. reduced its position in Cooper Companies, Inc. (The) (NYSE:COO) by 15.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 250,082 shares of the medical device company’s stock after selling 46,678 shares during the quarter. Los Angeles Capital Management & Equity Research Inc. owned about 0.51% of Cooper Companies, Inc. (The) worth $59,297,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of COO. Advisory Services Network LLC boosted its holdings in shares of Cooper Companies, Inc. (The) by 30.6% in the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock valued at $109,000 after acquiring an additional 107 shares during the period. YorkBridge Wealth Partners LLC boosted its holdings in shares of Cooper Companies, Inc. (The) by 2.1% in the second quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock valued at $126,000 after acquiring an additional 11 shares during the period. Acrospire Investment Management LLC lifted its holdings in shares of Cooper Companies, Inc. (The) by 50.0% during the second quarter. Acrospire Investment Management LLC now owns 600 shares of the medical device company’s stock worth $144,000 after purchasing an additional 200 shares during the period. Canada Pension Plan Investment Board acquired a new stake in shares of Cooper Companies, Inc. (The) during the third quarter worth $163,000. Finally, Visionary Asset Management Inc. acquired a new stake in shares of Cooper Companies, Inc. (The) during the second quarter worth $201,000. 96.71% of the stock is owned by institutional investors and hedge funds.

Several equities research analysts recently weighed in on COO shares. Zacks Investment Research downgraded Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a report on Monday, September 18th. KeyCorp reaffirmed a “hold” rating on shares of Cooper Companies, Inc. (The) in a report on Monday, August 28th. Robert W. Baird reaffirmed a “buy” rating and set a $267.00 price target (up from $251.00) on shares of Cooper Companies, Inc. (The) in a report on Sunday, September 3rd. BidaskClub downgraded Cooper Companies, Inc. (The) from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. Finally, BMO Capital Markets reaffirmed a “buy” rating and set a $272.00 price target on shares of Cooper Companies, Inc. (The) in a report on Friday, October 13th. Seven investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $261.11.

TRADEMARK VIOLATION WARNING: This piece was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://ledgergazette.com/2017/11/13/cooper-companies-inc-the-coo-shares-sold-by-los-angeles-capital-management-equity-research-inc.html.

Cooper Companies, Inc. (NYSE COO) traded down $2.89 during trading on Monday, reaching $229.06. The company’s stock had a trading volume of 341,800 shares, compared to its average volume of 428,798. Cooper Companies, Inc. has a 12 month low of $158.73 and a 12 month high of $256.39. The company has a current ratio of 2.51, a quick ratio of 1.29 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $11,510.00, a P/E ratio of 24.50, a P/E/G ratio of 1.97 and a beta of 0.55.

Cooper Companies, Inc. (The) (NYSE:COO) last released its earnings results on Thursday, August 31st. The medical device company reported $2.64 EPS for the quarter, beating analysts’ consensus estimates of $2.58 by $0.06. Cooper Companies, Inc. (The) had a return on equity of 16.00% and a net margin of 16.45%. The company had revenue of $556.00 million during the quarter, compared to the consensus estimate of $552.32 million. During the same quarter last year, the company earned $2.30 earnings per share. Cooper Companies, Inc. (The)’s quarterly revenue was up 8.0% compared to the same quarter last year. equities analysts anticipate that Cooper Companies, Inc. will post 9.72 EPS for the current fiscal year.

In other Cooper Companies, Inc. (The) news, Director Gary S. Petersmeyer sold 3,977 shares of the firm’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $244.94, for a total value of $974,126.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is currently owned by company insiders.

Cooper Companies, Inc. (The) Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply